Philip Morris International Inc.
185.71USD
+0.9800 (+0.53%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.25▼ | $2.43 | 0 | 8 |
| Next quarter | $1.96▼ | $1.96 | 2 | 5 |
| Current year | $8.38▼ | $8.41 | 2 | 9 |
| Next year | $9.17▲ | $9.14 | 4 | 7 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.05 | $2.2 | +0.15 (+7.3%) |
| 2026-03-31 | $1.83 | $1.96 | +0.13 (+7.1%) |
| 2025-12-31 | $1.7 | $1.7 | +0.00 (+0.0%) |
| 2025-09-30 | $2.1 | $2.24 | +0.14 (+6.9%) |
203 ratings from 26 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Buy | $210 $225 | Jul 30, 2026 |
| Barclays | Maintained | Overweight | $205 $225 | Jul 29, 2026 |
| Morgan Stanley | Maintained | Overweight | $200 $215 | Jul 23, 2026 |
| Stifel | Maintained | Buy | $195 $205 | Jul 23, 2026 |
| Needham | Maintained | Buy | $200 $215 | Jul 23, 2026 |
| UBS | Maintained | Neutral | $168 $182 | Jul 2, 2026 |
| Morgan Stanley | Maintained | Overweight | $190 $200 | Jun 3, 2026 |
| Needham | Reiterated | Buy | $200 | Apr 23, 2026 |
| UBS | Maintained | Neutral | $181.5 $168 | Apr 17, 2026 |
| Morgan Stanley | Maintained | Overweight | $205 $190 | Apr 17, 2026 |
| Needham | Maintained | Buy | $205 $200 | Apr 13, 2026 |
| Stifel | Maintained | Buy | $200 $195 | Apr 10, 2026 |
| Citigroup | Maintained | Buy | $200 $210 | Feb 10, 2026 |
| Needham | Maintained | Buy | $190 $205 | Feb 10, 2026 |
| Jefferies | Downgraded from Buy | Hold | $220 $180 | Jan 20, 2026 |
| JP Morgan | Maintained | Overweight | $190 $185 | Nov 26, 2025 |
| Barclays | Maintained | Overweight | $220 $180 | Nov 17, 2025 |
| UBS | Maintained | Neutral | $177 $166 | Sep 5, 2025 |
| Barclays | Maintained | Overweight | $225 $220 | Jul 30, 2025 |
| Needham | Reiterated | Buy | $195 | Jul 23, 2025 |
| UBS | Maintained | Neutral | $170 $181 | Jul 14, 2025 |
| Citigroup | Maintained | Buy | $188 $200 | Jul 10, 2025 |
| JP Morgan | Maintained | Overweight | $175 $190 | Jul 10, 2025 |
| Barclays | Maintained | Overweight | $220 $225 | Jul 10, 2025 |
| Jefferies | Initiated | Buy | $220 | Jul 9, 2025 |
58 filings from 21 insiders · 0 buy / 0 sell over 6m
Officers and directors of PM, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BOUGH BONINDirector | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| POLET ROBERTDirector | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| CALANTZOPOULOS ANDREChairman of the Board | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| HARKER VICTORIA DDirector | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| HOOK LISA A.Director | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| GEISSLER WERNERDirector | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| YANAI SHLOMODirector | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| COMBES MICHELDirector | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| MORPARIA KALPANADirector | Grant | 1.1k | $169.93 | $190k | May 6, 2026 |
| DOBROWOLSKI REGINALDOOfficer | Sell | 6.0k | $183.46 | $1.10M | Feb 20, 2026 |
| KENNEDY STACEYOfficer | Sell | 14.3k | $183.13 | $2.63M | Feb 20, 2026 |
| BABEAU EMMANUELOfficer | Sell | 33.8k | $181.61 | $6.14M | Feb 19, 2026 |
| GUERIN YANNOfficer | Sell | 4.0k | $181.69 | $727k | Feb 19, 2026 |
| DE WILDE FREDERIC JOfficer | Sell | 20.0k | $182.58 | $3.65M | Feb 19, 2026 |
| OLCZAK JACEKOfficer and Director | Sell | 80.0k | $182.18 | $14.57M | Feb 19, 2026 |
| DOBROWOLSKI REGINALDOOfficer | Grant | 6.5k | — | $467k | Feb 6, 2026 |
| GUERIN YANNOfficer | Grant | 8.3k | — | $873k | Feb 6, 2026 |
| OLCZAK JACEKOfficer and Director | Grant | 171.0k | — | $5.79M | Feb 6, 2026 |
| DE WILDE FREDERIC JOfficer | Grant | 33.1k | — | $1.84M | Feb 6, 2026 |
| BABEAU EMMANUELOfficer | Grant | 61.4k | — | $1.96M | Feb 6, 2026 |
No analyst notes on PM yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 9 | 4 | 0 | 0 | Buy2.06 |
| 1 mo ago | 4 | 7 | 4 | 0 | 0 | Buy2.00 |